Stockscreener 앱 받기
4.44
2.20%
-0.10
시간 외 거래:
4.54
0.10
+2.25%
전일 마감가:
$4.54
열려 있는:
$4.4
하루 거래량:
35,305
Relative Volume:
0.03
시가총액:
$4.59M
수익:
-
순이익/손실:
$-6.90M
주가수익비율:
-0.3168
EPS:
-14.0152
순현금흐름:
$-6.65M
1주 성능:
-1.11%
1개월 성능:
+165.87%
6개월 성능:
+18.09%
1년 성능:
-31.90%
1일 변동 폭
$4.24
$4.59
1주일 범위
$4.24
$4.93
52주 변동 폭
$1.6233
$16.68
Bluejay Diagnostics Inc Stock (BJDX) Company Profile
명칭
Bluejay Diagnostics Inc
전화
(978) 631-0152
주소
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
Compare BJDX vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BJDX
Bluejay Diagnostics Inc
|
4.44 | 4.97M | 0 | -6.90M | -6.65M | -14.02 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bluejay Diagnostics Inc 주식(BJDX)의 최신 뉴스
Bluejay Diagnostics Inc. (BJDX) Q4 2023 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances PipelineOne-Time Gain Impact - newsline.com
BJDX Q4 2023 Earnings: EPS Misses Estimates by Wide Margin as No Revenue ReportedFull Year Guidance - newsline.com
BJDX Q4 2023 Earnings: Significant EPS Miss Amid Pre-Revenue StageMargin Guidance - newsline.com
Bluejay Diagnostics Shareholders Approve Stock Plan and Flexibility - TipRanks
Bluejay Diagnostics (NASDAQ: BJDX) expands stock plan and wins reverse split approval - Stock Titan
BLUEJAY DIAGNOSTICS INC (BJDX) Stock Chart - ChartMill
Bluejay Diagnostics Completes Private Placement to Extend Runway - TipRanks
Bluejay Diagnostics Raises $7.7 Million in Private Placement, Issues Pre-Funded and 5-Year Warrants - TradingView
Bluejay Diagnostics (NASDAQ: BJDX) closes $8.5M warrant-backed financing - Stock Titan
Bluejay Diagnostics completes private placement that raised USD 8.5M - Medical Buyer
Bluejay Diagnostics closes $8.5 million private placement By Investing.com - Investing.com Australia
Bluejay Diagnostics closes $8.5 million private placement - Investing.com
Bluejay Diagnostics, Inc. Closes $8.5 Million Private Placement to Extend Cash Runway for FDA Approval and Commercialization - Moomoo
Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Yahoo Finance Australia
[SCHEDULE 13G] Bluejay Diagnostics, Inc. Passive Investment Disclosure (>5%) - Stock Titan
What's going on with Bluejay Diagnostics shares on Wednesday? - MSN
Bluejay Diagnostics, Inc. announced that it has received $8.500007 million in funding - marketscreener.com
BJDX Q4 2023 Earnings: Significant EPS Miss Despite Revenue Absence Drives Stock SurgeTech Earnings Analysis - newsline.com
What's Going On With Bluejay Diagnostics Shares On Wednesday? - Benzinga
Bluejay Diagnostics Forms U.S. Manufacturing Partnership for Symphony - The Globe and Mail
Bluejay Diagnostics, Argonaut Manufacturing Services join hands - Medical Buyer
Northstrive Fund II and Braeden Lichti exit Bluejay Diagnostics (BJDX) stake - Stock Titan
Large Bluejay Diagnostics (BJDX) holder reports full exit in 13G/A - Stock Titan
Bluejay's Domestic Pivot: De-Risking the Long Road to Market - BriefGlance
Bluejay Diagnostics raises $8.5M in private placement By Investing.com - Investing.com Nigeria
Bluejay Diagnostics Inc has disclosed a private placement plan with a maximum financing amount of $23.6 million. - Bitget
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Bluejay Diagnostics Stock Nearly Triples After U.S. Manufacturing Deal — Here’s the FDA Catch - TechStock²
Bluejay Diagnostics raises $8.5M in private placement - Investing.com
Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules - The Manila Times
Press Release: Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules - Moomoo
Bluejay Diagnostics Partners with Argonaut Manufacturing to Advance U.S. Production of Symphony Platform for Critical Care Diagnostics 1 - Minichart
Bluejay Diagnostics, Argonaut Manufacturing Services Collaborate on Development of Symphony Testing Platform - Moomoo
Bluejay Diagnostics partners with Argonaut to boost US manufacturing for its Symphony™ diagnostic platform - Pluang
Bluejay Diagnostics surges 163% on strategic U.S. manufacturing partnership tied to Symphony platform - Quiver Quantitative
Why is Bluejay Diagnostics stock soaring Tuesday? - MSN
Trending Stocks Today | Decent Holding Soars 222.5% - Moomoo
BJDX Stock Rockets On Massive Volume As Traders Pile In - StocksToTrade
Bluejay Diagnostics Gains Pre-Market on U.S. Manufacturing Agreement - TechStock²
Why Is Penny Stock Bluejay Diagnostics (BJDX) Up Today? - TipRanks
BJDX Stock Jumps As Traders Zero In On Volatility - timothysykes.com
Why Is Bluejay Diagnostics Stock Soaring Tuesday? - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Bluejay Diagnostics partners with Argonaut for US manufacturing By Investing.com - Investing.com Canada
Bluejay Diagnostics And Argonaut Manufacturing Services Announce Strategic Partnership - TradingView
Bluejay Diagnostics Partners with Argonaut Manufacturing Services to Enhance U.S. Manufacturing for Symphony™ Platform - Quiver Quantitative
Bluejay Diagnostics partners with Argonaut for US manufacturing - Investing.com
US manufacturing pact backs Bluejay (NASDAQ: BJDX) Symphony platform - Stock Titan
Bluejay Diagnostics, Inc. and Argonaut Manufacturing Services Announce Strategic Partnership - marketscreener.com
BJDX Q4 2023 Earnings: Wide EPS Miss Amidst Pre-Revenue Pipeline ProgressRevenue Growth Report - newsline.com
Bluejay Diagnostics, Inc. announced that it expects to receive $8.500007 million in funding - marketscreener.com
Bluejay Diagnostics Inc (BJDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Bluejay Diagnostics Inc 주식 (BJDX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Dey Indranil | President and CEO |
Mar 14 '26 |
Buy |
2.00 |
12,500 |
25,000 |
12,522 |
| CHASE DONALD R | Director |
Mar 14 '26 |
Buy |
2.00 |
12,500 |
25,000 |
12,525 |
| ZEIDMAN FRED S | Director |
Mar 14 '26 |
Buy |
2.00 |
12,500 |
25,000 |
12,500 |
| Dey Svetlana | Director |
Mar 14 '26 |
Buy |
2.00 |
12,500 |
25,000 |
12,501 |
2.43%
자본화:
|
볼륨(24시간):